The 14th Asian Congress of Nutrition took place from September 14th to 17th, 2023, in Chengdu, China. Novozymes OneHealth showcased innovative technology and the latest research findings at this nutrition congress and signed a strategic cooperation agreement with Hubei Junyao Health, which is a leading company in the field of probiotics in China.
Dr. Berry’s team from Novozymes OneHealth, in collaboration with experts from APC Microbiome Ireland, conducted scientific testing to select strains that have significant benefits for human health, resulting in IBme™ (Bifidobacterium lactis 35624®) and ProbioBrain™ (Bifidobacterium lactis 1714®). The official introduction of these two unique strains to the Chinese market not only represents Novozymes’ bio-based solutions for modern health challenges, but also serves as a significant step in advancing the development of the nutrition and health industry in China. (Source: foodmate-gnspq)
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE